Entera Bio Ltd

ENTXNASDAQ · USD
3.03USD-0.08 (-2.74%)
2110

Entera Bio Ltd (ENTX) Option Chain

Read more

Tracking the ENTX option chain helps you see every strike and expiry on Entera Bio Ltd in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ENTX options activity at a glance. Use our scanner to monitor the ENTX option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ENTX stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ENTX options are being actively traded, and where they are not.

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.74000.372.030.104.701.00-67.85—2.550.002.550099.26
20.661302.671.03—3.702.00-35.69—2.550.002.550179.34
55.111,6201261.170.03—1.203.00-3.54—0.900.000.9004244.89
78.8123800.250.00—0.254.00+28.62—1.550.970.580121.19
90.671100.950.00—0.955.00+60.770.902.451.97-0.30009.33

As of Nov 13, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank29.37% Low
  • Market cap (M$)542
  • 52 weeks high-25.95%
  • 52 weeks low241.76%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$10.00
    230.58% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-06
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.39
  • EPS growth next 5 years-16.72%

As of Nov 13, 2026